Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lexeo Therapeutics Inc (LXEO)

Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lexeo Therapeutics Inc 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 USA

www.lexeotx.com Employees: 72 P: 212-547-9879

Sector:

Medical

Description:

Lexeo Therapeutics is a clinical-stage genetic medicine company which defined cardiovascular diseases and APOE4-associated Alzheimer's disease are treated. Lexeo Therapeutics is based in New York City.

Key Statistics

Overview:

Market Capitalization, $K 761,984
Enterprise Value, $K 726,974
Shares Outstanding, K 72,987
Annual Sales, $ 0 K
Annual Net Income, $ -98,330 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,280 K
EBIT, $ -113,530 K
EBITDA, $ -113,230 K
60-Month Beta 1.76
% of Insider Shareholders 5.30%
% of Institutional Shareholders 60.67%
Float, K 69,119
% Float 94.70%
Short Interest 6,037
Short Float 8.27%
Short Volume Ratio 0.78

Growth:

1-Year Return 66.77%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 11/05/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -2.70
EPS Growth vs. Prev Qtr 45.00%
EPS Growth vs. Prev Year 62.92%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

LXEO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -90.49%
Return-on-Assets % -70.86%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.83
Book Value/Share 2.20
Interest Coverage -701.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar